Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study

Clin Exp Allergy. 2021 Oct;51(10):1391-1395. doi: 10.1111/cea.13974. Epub 2021 Jul 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedemas, Hereditary* / diagnosis
  • Angioedemas, Hereditary* / drug therapy
  • Angioedemas, Hereditary* / prevention & control
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Quality of Life

Substances

  • Antibodies, Monoclonal, Humanized
  • lanadelumab